SKI Market

Indian Indices

Sensex

81,287.19 -961.42
( -1.17%)

Global Indices

Nasdaq

48,844.08 -676.12
(-1.37%)

Dow Jones

6,870.91 -58.95
(-0.85%)

Hang Seng

58,843.60 90.21
(0.15%)

Nikkei 225

10,926.32 79.62
(0.73%)

Forex

USD-INR

90.92 -0.01
(-0.01%)

EUR-INR

107.23 0.12
(0.12%)

GBP-INR

122.98 0.28
(0.22%)

JPY-INR

0.58 0.00
(-0.40%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

218.44

48.76

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

fervent synergies ltd

Grameva standalone net profit declines 43.75% in the December 2025 quarter

Feb 14,2026

Net profit of Grameva declined 43.75% to Rs 0.09 crore in the quarter ended December 2025 as against Rs 0.16 crore during the previous quarter ended December 2024. Sales rose 128.55% to Rs 12.57 crore in the quarter ended December 2025 as against Rs 5.50 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	12.57	5.50	129
OPM %	0.32	6.36	-
PBDT	0.20	0.31	-35
PBT	0.11	0.22	-50
NP	0.09	0.16	-44

81,287.19 -961.42 ( -1.17%)

48,844.08 -676.12 (-1.37%)

6,870.91 -58.95 (-0.85%)

58,843.60 90.21 (0.15%)

10,926.32 79.62 (0.73%)

90.92 -0.01 (-0.01%)

107.23 0.12 (0.12%)

122.98 0.28 (0.22%)

0.58 0.00 (-0.40%)